Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

METHOCARBAMOL Drug Profile

« Back to Dashboard

Which patents cover Methocarbamol, and what generic alternatives are available?

Methocarbamol is a drug marketed by Hetero Labs Ltd Iii, Mylan Institutional, Watson Labs, Able, Sandoz, Renaissance Ssa Llc, Am Therap, Purepac Pharm, Hikma Intl Pharms, Mylan, Heather, Impax Labs, Aurobindo Pharma Ltd, Pioneer Pharms, Puracap Pharm, Nylos, Inwood Labs, Roxane, Tablicaps, Ivax Sub Teva Pharms, Solvay, Marsam Pharms Llc, Atlas Pharms Llc, Upsher Smith, Monterey Pharms Llc, Lannett Holdings Inc, Austarpharma Llc, Kv Pharm, Ascot, Clonmel Hlthcare, Sun Pharm Inds, Prinston Inc, Superpharm, Vintage Pharms, Stevens J, Par Pharm, and Mcneil. and is included in sixty-three NDAs.

The generic ingredient in METHOCARBAMOL is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.

Summary for Tradename: METHOCARBAMOL

Patents:0
Applicants:37
NDAs:63
Suppliers / Packagers: see list55
Bulk Api Vendors: see list59
Clinical Trials: see list1
Patent Applications: see list1,465
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METHOCARBAMOL at DailyMed

Pharmacology for Tradename: METHOCARBAMOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Austarpharma Llc
METHOCARBAMOL
methocarbamol
TABLET;ORAL200958-002Oct 21, 2011AARXNoNo► Subscribe► Subscribe
Solvay
METHOCARBAMOL
methocarbamol
TABLET;ORAL084449-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Clonmel Hlthcare
METHOCARBAMOL
methocarbamol
TABLET;ORAL085961-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Prinston Inc
METHOCARBAMOL
methocarbamol
TABLET;ORAL086988-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe
Mylan
METHOCARBAMOL
methocarbamol
TABLET;ORAL084259-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot